Applied Therapeutics Inc (APLT) - News Archive

In a strategic move aimed at bolstering its operational integrity, Applied Therapeutics Inc. has appointed Reena Thomas Colacot as Vice President and Head of Quality. Ms. Colacot arrives with over 25 years of quality le...

The realm of pharmaceutical investments often presents a delicate interplay between innovation and accountability. Recent legal developments concerning Applied Therapeutics, Inc. (NASDAQ: APLT) underscore the significan...

In recent developments regarding Applied Therapeutics, Inc. (NASDAQ: APLT), legal counsel from the renowned Rosen Law Firm has issued an important reminder to investors concerning impending deadlines related to a securi...

The pharmaceutical landscape is often fraught with high stakes and heightened investor expectations, particularly when it comes to the development of new drugs. In late 2024, Applied Therapeutics, Inc. (NASDAQ: APLT), a...

In an unexpected turn of events, Applied Therapeutics, Inc. has appointed John H. Johnson as Executive Chairman, a move that coincides with the departure of Shoshana Shendelman as CEO and the appointment of Les Funtleyd...

In recent weeks, Applied Therapeutics, Inc. (NASDAQ: APLT) has become the focal point of investor scrutiny following the announcement of a class action lawsuit alleging that the company made materially false or misleadi...

FDA Issues Complete Response Letter to Applied Therapeutics Govorestat NDA for Classic Galactosemia TreatmentIn a move that underscores the rigorous scrutiny involved in approving novel therapeutics, the U.S. Food and D...

Navigating New Frontiers in Rare Disease Treatment: Applied Therapeutics Promising Developments Applied Therapeutics Provides Regulatory Updates and Positive Interim Results for Govorestat Late-Cycle Review Meeting with...

In recent news, Applied Therapeutics, a clinical-stage biopharmaceutical company, announced an update regarding the New Drug Application (NDA) for govorestat (AT-007), a potential treatment for Classic Galactosemia. The...

Applied Therapeutics Announces $100 Million Private PlacementApplied Therapeutics Inc, a leading biopharmaceutical company, has recently announced a significant milestone in its financing endeavors. The company has succ...

This article discusses the recent announcement by Applied Therapeutics Inc. regarding the FDA s acceptance and priority review of the New Drug Application (NDA) for Govorestat, an investigational drug for the treatment...

In the field of pharmaceutical sciences, continuous research and development efforts to find better treatment options for rare genetic disorders have led to significant advancements. In this context, Applied Therapeutic...